The active-manager-heavy accumulation suggests a shared catalyst thesis (likely market share gains or pipeline progress in aesthetic injectables). However, the 45-day reporting lag and absence of insider buying reduce conviction. Monitor upcoming earnings or FDA/regulatory updates for catalyst confirmation.
Executive Summary
Five institutional investors accumulated $11.6M in net new EOLS positions during Q2 2026, led by State Street (+$6.4M) and Assenagon (+$3.8M), while only two small sellers trimmed negligible amounts. The cluster is dominated by active asset managers (Assenagon, Citigroup, PNC, Nuveen) and one mega-passive (State Street), with no insider buying to corroborate the signal. The strong active-manager conviction suggests a shared thesis around Evolus' aesthetic injectables pipeline or market share gains, but the 45-day reporting lag means positions may have been adjusted since quarter-end.
Key Financial Metrics
Institutional Positions
Net institutional flow: $11.6M
▲ Buyers (5)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Assenagon Asset Management | ADD | +51.8% | $6.3M | $3.8M |
| Citigroup | DOUBLED | +571.2% | $298.0K | $272.0K |
| State Street | ADD | +28.5% | $11.8M | $6.4M |
| Pnc Financial Services Group | ADD | +64.9% | $20.0K | $13.0K |
| Nuveen | DOUBLED | +109.3% | $1.6M | $1.2M |
▼ Sellers (2)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Optiver Holding B.v. | NEAR_EXIT | -89.6% | $1.0K | -$1.2K |
| Clearstead Advisors | TRIM | -50% | $141.00 | -$22.00 |
Key Facts
- 5 institutional buyers added $11.6M net in Q2 2026, with State Street (+$6.4M) and Assenagon (+$3.8M) as largest
- 2 sellers (Optiver, Clearstead) trimmed only $1,232 combined — negligible
- Active managers dominate the buying: Assenagon (ADD +51.8%), Citigroup (DOUBLED +571%), Nuveen (DOUBLED +109%)
- No open-market insider buying in the window — institutions-only signal
- 13F data reflects quarter-end positions with 45-day lag; current holdings may differ
Financial Impact
5 institutions accumulated $11.6M in net new positions; 2 sellers reduced by $1,232
Risk Factors
- 13F data is 45+ days stale; positions may have been unwound
- No insider buying to corroborate the institutional signal
- Small float could amplify moves but also increase volatility risk
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-EOLS-2026-Q2 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 13, 2026 10w ago | Institutional Cluster | $8.02 $8.16 | ▲ +1.68% | ▲ +1.88% | — |
Aug 4, 2026 11w ago | 8-K | $6.12 $6.18 | ▲ +0.98% | ▲ +1.18% | — |
Jul 8, 2026 15w ago | 8-K | $6.79 $6.85 | ▲ +0.88% | ▲ +0.04% | — |
Jun 15, 2026 19w ago | EFFECT | $6.75 $6.63 | ▼ −1.78% | ▼ −1.18% | — |
Jun 5, 2026 20w ago | S-3 | $6.68 $6.70 | ▲ +0.30% | ▲ +0.59% | — |
Apr 29, 2026 25w ago | DEFA14A | $5.18 $5.39 | ▲ +4.05% | ▲ +3.03% | — |
Mar 17, 2026 32w ago | Insider Cluster | $4.91 $4.83 | ▲ +1.63% | ▲ +0.23% | — |
Mar 17, 2026 32w ago | Insider Cluster | $4.91 $4.83 | ▲ +1.63% | ▲ +0.23% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers